Background Territorial differences in the access to innovative anticancer drugs have been reported from many countries.
Secondary objectives are to describe the characteristics of this patient population and their management, and to estimate one, four and five-year survival rates.
Filippo de Marinis.
There is no clear association between passive smoke exposure and somatic profile in lifelong, never-smoker lung cancer.
Description: Pour chaque service participant, les resultats recueillis pourront servir de base a un suivi regulier au cours du temps de leur structure et leur activite. This work from an expert group, based on the review of the data from the Profile studies, aims to provide practical elements in order to optimize the tolerability of crizotinib.